ABOUT THE PRODUCT
ImmuneCyte is developing a next-generation CAR-T cell therapy platform targeting various cancers. This innovative approach utilizes enhanced T-cell engineering to improve efficacy and reduce side effects.
Information is owner-confirmed
Last updated 2 weeks ago
Price range
Other products/services from ImmuneCyte, Inc.

CAR-NK Cell Therapy
Biotechnology
N/A
ImmuneCyte, Inc.
United States (US)